Live Tumor Board: Squamous Cell Carcinoma of the Head & Neck - Post-CRT Decisions in the Locally Advanced Setting

Thanks for your interest in this podcast. Please read this important program information before listening.

Episode Description

In this podcast, experts Barbara Burtness, MD; and Quynh-Thu Le, MD, FACR, FASTRO; discuss recent and ongoing trials and key updates in the management of locally advanced head and neck cancer.

Learning Objectives

Upon successful completion of this activity, you should be better prepared to:

• Identify potentially eligible patients for ongoing clinical trials evaluating novel treatment approaches following chemoradiotherapy

Acknowledgment of Educational Grant Support

This activity is supported by an educational grant from AstraZeneca Pharmaceuticals.

Chair:

Barbara Burtness, MD

Anthony N. Brady Professor of Medicine
Chief Translational Research Officer
Chief, Head and Neck Cancers/Sarcoma
Yale Cancer Center
New Haven, CT

Disclosures: Advisor, Consultant, Speaker, Honoraria Recipient: ALX Oncology, Answers in CME, AstraZeneca, ClearView Healthcare Partners, Clinical Care Options LLC, Coherus Biosciences, Genentech, Genmab, GSK, Induxion, IO Biotech, Janssen Pharmaceuticals, Med Learning Group, Merck, Merck KGaA, Merus, OncLive, One Carbon, Pfizer, PRIME, Rakuten, Takeda Pharmaceuticals, UpToDate, Yale School of Medicine; Grant/Research Funding (to institution): GSK, IO Biotech, Janssen Pharmaceuticals, Merck; Royalty or Patent Benefits: UpToDate

Faculty:

Quynh-Thu Le, MD, FACR, FASTRO

Katharine Dexter McCormick and
Stanley McCormick Memorial Professor
Chair, Department of Radiation Oncology
Stanford University
Stanford, CA

Disclosures: Executive Role: NRG Oncology Group Chair, Radiation Therapy Oncology Group Foundation Chair

Faculty, Staff, and Planners’ Disclosures

In accordance with ACCME Guidelines, PER^® has identified and resolved all conflict of interest for faculty, staff, and planners prior to the start of this activity by using a multistep process.

The staff of Physicians’ Education Resource^®, LLC have no relevant financial relationships with ineligible companies.

This podcast, including the narration, was developed by PER^® editorial staff based on an online activity developed with these faculty. The narration was voiced by a PER staff member or by an AI tool.

To learn more about this topic, including information on surgical approaches to head and neck cancer, go to https://www.gotoper.com/ltb26squamous-activity.

Release Date

April 17, 2026

Expiration Date

April 17, 2027

Off-Label Disclosure and Disclaimer

This activity may or may not discuss investigational, unapproved, or off-label use of drugs. Learners are advised to consult prescribing information for any products discussed. The information provided in this accredited activity is for continuing education purposes only and is not meant to substitute for the independent clinical judgment of a health care professional relative to diagnostic, treatment, or management options for a specific patient’s medical condition. The opinions expressed in the content are solely those of the individual faculty members and do not reflect those of PER^® or any company that provided commercial support for this activity.